1.上海中医药大学附属市中医医院脑病科(上海 200071)
高晗,女,硕士,住院医师,主要从事中医药治疗神经变性疾病的临床研究
李文涛,主任医师、教授,硕士生导师;E-mail:lwt1132@163.com
扫 描 看 全 文
高晗, 蔡丽, 王炜为, 等. 补肾止颤方加减治疗肝肾不足型帕金森病的随机对照研究[J]. 上海中医药大学学报, 2021,35(2):8-11.
GAO Han, CAI Li, WANG Weiwei, et al. Modified Bushen Zhichan Decoction in the treatment of Parkinson’s disease with syndrome of deficiency of liver and kidney: A randomized controlled study[J]. Academic Journal of Shanghai University of Traditional Chinese Medicine, 2021,35(2):8-11.
高晗, 蔡丽, 王炜为, 等. 补肾止颤方加减治疗肝肾不足型帕金森病的随机对照研究[J]. 上海中医药大学学报, 2021,35(2):8-11. DOI: 10.16306/j.1008-861x.2021.02.002.
GAO Han, CAI Li, WANG Weiwei, et al. Modified Bushen Zhichan Decoction in the treatment of Parkinson’s disease with syndrome of deficiency of liver and kidney: A randomized controlled study[J]. Academic Journal of Shanghai University of Traditional Chinese Medicine, 2021,35(2):8-11. DOI: 10.16306/j.1008-861x.2021.02.002.
目的:,2,观察补肾止颤方加减治疗肝肾不足型帕金森病(PD)的临床疗效。,方法:,2,纳入肝肾不足型PD患者80例,采用随机数字表分为治疗组和对照组,每组40例。对照组患者给予常规西药治疗,治疗组患者给予常规西药结合补肾止颤方加减口服治疗,治疗周期为12周,治疗结束后随访12周。治疗前及治疗12周、24周后,评价并比较两组患者的统一PD评定量表(UPDRS)、非运动症状量表(NMSS)、PD患者生活质量问卷(PDQ-39)、疲劳严重度量表(FSS)评分及中医证候积分。,结果:,2,治疗过程中,治疗组7例患者脱落或剔除,对照组8例患者脱落或剔除,最终治疗组33例、对照组32例纳入统计分析。治疗12周、24周后,治疗组患者的UPDRS评分较治疗前有所下降,而对照组有所上升,但差异均无统计学意义(,P,>,0.05);治疗24周后,治疗组患者的UPDRS评分明显低于对照组(,P,<,0.05)。治疗后,治疗组患者的NMSS、PDQ-39、FSS评分及中医证候积分较治疗前均明显降低(,P,<,0.05,,P,<,0.01),且治疗组患者的NMSS、PDQ-39、FSS评分及中医证候积分均显著低于对照组(,P,<,0.05,,P,<,0.01)。,结论:,2,补肾止颤方加减可有效改善肝肾不足型PD患者的非运动症状和生活质量,缓解患者运动症状的进展,值得在临床中推广应用。
Objective:,2,To observe the clinical efficacy of Modified Bushen Zhichan Decoction in the treatment of Parkinson’s disease(PD) with syndrome of deficiency of liver and kidney.,Methods:,2,Eighty PD patients with syndrome of deficiency of liver and kidney were included and randomly divided into the treatment group and control group according to random number table, 40 cases in each group.The patients in the control group were treated with conventional western medicine and the patients in the treatment group were orally treated with conventional western medicine combined with Modified Bushen Zhichan Decoction, with a treatment course of 12 weeks and follow-up for 12 weeks after treatment.Before treatment and after treatment for 12 weeks and 24 weeks, the scores of unified Parkinson’s disease rating scale(UPDRS), non-motor symptom scale(NMSS), Parkinson’s disease questionnaire on quality of life(PDQ-39) and fatigue severity scale(FSS) and the Chinese medical syndrome score were evaluated and compared.,Results:,2,In the course of treatment, 7 patients in the treatment group and 8 patients in the control group shed or were excluded.Finally, 33 cases in the treatment group and 32 cases in the control group were included in the statistical analysis.After treatment for 12 weeks and 24 weeks, the UPDRS scores of the treatment group showed a downward trend and the UPDRS scores of the control group showed an upward trend compared with those before treatment, but with no statistically significant differences(,P,>,0.05) .After treatment for 24 weeks, the UPDRS score of the treatment group was significantly lower than that of the control group(,P,<,0.05) .After treatment, the scores of NMSS, PDQ-39, FSS and Chinese medical syndrome in the treatment group were significantly decreased compared with those before treatment(,P,<,0.05,P,<,0.01), and the scores of NMSS, PDQ-39, FSS and Chinese medical syndrome in the treatment group were significantly lower than those in the control group(,P,<,0.05,P,<,0.01) .,Conclusion:,2,Modified Bushen Zhichan Decoction can effectively improve the non-motor symptoms and life quality of PD patients with syndrome of deficiency of liver and kidney, and alleviate the development of motor symptoms, which is worthy of clinical promotion and application.
帕金森病肝肾不足型补肾止颤方随机对照研究
Parkinson’s diseasesyndrome of deficiency of liver and kidneyBushen Zhichan Decoctionrandomized controlled study
SALARI S,BAGHERI M. In vivo,in vitro and pharmacologic models of Parkinson’s disease[J]. Physiol Res,2019,68(1):17-24.
李文蒿,高晗,李文涛.中医药治疗帕金森病的研究进展[J].中西医结合心脑血管病杂志,2020,18(8):1244-1246.
中华医学会神经病学分会帕金森病及运动障碍学组,中国医师协会神经内科医师分会帕金森病及运动障碍专业委员会.中国帕金森病的诊断标准(2016版)[J].中华神经科杂志,2016,49(4):268-271.
中华全国中医学会老年医学会.中医老年颤证诊断和疗效评定标准[J].北京中医学院学报,1992,15(4):39-41.
HOEHN M M,YAHR M D. Parkinsonism:onset,progression and mortality[J]. Neurology,1967,17(5):427-442.
MARTINEZ-MARTIN P,SCHAPIRA A H V,STOCCHI F,et al. Prevalence of nonmotor symptoms in Parkinson’s disease in an international setting;study using nonmotor symptoms questionnaire in 545 patients[J]. Mov Disord,2007,22(11):1623-1629.
RASCOL O,FITZER-ATTAS C J,HAUSER R,et al. A double-blind,delayed-start trial of rasagiline in Parkinson’s disease(the ADAGIO study):prespecified and post-hoc analyses of the need for additional therapies,changes in UPDRS scores,and non-motor outcomes[J]. Lancet Neurol,2011,10(5):415-423.
王雁,李馨,李海燕,等.帕金森病非运动症状的量表介绍及评价[J].临床神经病学杂志,2015,28(4):314-316.
PETO V,JENKINSON C,FITZPATRICK R. Determining minimally important differences for the PDQ-39 Parkinson’s disease questionnaire[J]. Age Ageing,2001,30(4):299-302.
崔亚欢,陈乃耀.帕金森病的发病机制研究[J].中华老年心脑血管病杂志,2019,21(1):106-110.
林晶,沙地克·沙吾提.帕金森病的中医药治疗现状[J].新疆中医药,2018,36(5):封3-封4.
顾超,袁灿兴.帕金森病的中医证型分布和用药规律探析[J].上海中医药杂志,2013,47(7):12-14.
杨宁,过伟峰,刘卫国,等.300例帕金森病患者病机证素分布规律探讨[J].南京中医药大学学报,2016,32(6):540-542.
薛红,虢周科,刘璇.六味地黄丸对帕金森患者自主神经功能的影响[J].中医学报,2010,25(2):283-285.
LI W H,GAO H,LI W T. Effects of Combined Bushen Zhichan Recipe and Levodopa in a Rodent Model of Parkinson Disease:Potential Mechanisms[J]. Med Sci Monit,2020,26:e922345.
0
浏览量
274
下载量
0
CSCD
9
CNKI被引量
关联资源
相关文章
相关作者
相关机构